Uncertainty Quantification for Expensive COVID-19 Simulation Models (UQ4Covid)

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:21 publications

Grant number: EP/V051555/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $384,076.07
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Daniel Williamson
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Exeter
  • Research Priority Alignment

    N/A
  • Research Category

    13

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Accurate mathematical models of transmission are crucial for targeting successful interventions to combat the spread of SARS-Cov2. In the UK, established models are used to provide real time policy support to Government through the Scientific Pandemic Influenza group - Modelling (SPI-M). Modellers in SPI-M have a proven track record, and models are continually adapted to respond to the evolving pandemic. When using models to inform decision making, it is crucial that all sources of uncertainty are properly accounted for when calibrating and predicting. For 30 years the UK has been a world-leader in developing Uncertainty Quantification (UQ); delivering methods for formal treatments of uncertainty when using models to understand the world, allowing efficient and robust calibration and prediction. Despite this, these techniques are not currently in place for COVID-19 simulation models, leading to slower-than-necessary adaptive model development-UQ allows for fast re-calibration-and an under-representation of uncertainty in predictions delivered to policymakers. This project will adapt and deliver UQ techniques, code and tutorials for models of COVID-19 in the UK, providing SPI-M modellers with tools to facilitate rapid re-calibration of their models when changes are made in response to the evolving pandemic, and to more accurately represent uncertainty in their predictions. We will work closely with MetaWards, a spatial meta-population transmission framework (Danon et al. 2009, 2020) that contributes to SPI-M, to develop and apply these tools as we move into the winter; enabling fast evaluation of interventions responding to localised outbreaks, efficacy of vaccine rollout strategies, duration of immunity and more.

Publicationslinked via Europe PMC

Winter 2022-23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study.

Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022.

Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.

Clinical decision-making and algorithmic inequality.

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.

Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study.

Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.

Population disruption: observational study of changes in the population distribution of the UK during the COVID-19 pandemic

Estimation of reproduction numbers in real time: Conceptual and statistical challenges.